The Norwegian diagnostics company Genetic Analysis reports increased revenue during the fourth quarter compared with the same period the year before. The net loss increased. The board proposes no dividend. Revenue rose 3.2 percent to 6.4 million Norwegian kroner (6.2).The Ebitda result was -1.6 million Norwegian kroner (0.4). Result after tax was -2.6 million Norwegian kroner (-0.9). Earnings per share amounted to -0.04 Norwegian kroner (-0.02). No ordinary dividend is proposed (0).Genetic Analysis, MNOKQ4-2025Q4-2024ChangeRevenue6.46.23.2%Ebitda-1.60.4Ebitda margin6.5%Net income-2.6-0.9Earnings per share, NOK-0.04-0.02Ordinary annual dividend per share, NOK00